Advertisement
Screener

PROFOUND MEDICAL CORP. (PROF) Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss

2.8 / 5 stars · 68/120 Roast Me

PROFOUND MEDICAL CORP. Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss

PROFOUND MEDICAL CORP. (PROF) reported Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss of -$575.00 thousand for the 12-month period ending 2023-12-31, per its 40-F filed 2024-03-07.

Discontinued › Expense Statement › Operating Expenses

ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss · last filed 2024-03-07

CAD

Period endGains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 12 month
2019-12-31-153.98K CAD
40-F · filed 2020-03-03
2018-12-31-214.23K CAD
40-F · filed 2020-03-03

USD

Period endGains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 12 month
2023-12-31-$575.00K
40-F · filed 2024-03-07
2022-12-31$3.10M
40-F · filed 2024-03-07
2021-12-31-$286.00K
40-F · filed 2023-03-07
2020-12-31-$2.54M
40-F · filed 2022-03-03
2019-12-31-$1.00K
40-F · filed 2021-03-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neuronetics, Inc. (STIM)United States$0.216B-3.25
PRO DEX INC (PDEX)United States$0.234B13.64
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Lucid Diagnostics Inc. (LUCD)United States$0.170B
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
KORU Medical Systems, Inc. (KRMD)United States$0.151B-106.78
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92